TY  - JOUR
AU  - Guardo, Alberto C
AU  - Gómez, Carmen Elena
AU  - Díaz-Brito, Vicens
AU  - Pich, Judit
AU  - Arnaiz, Joan Albert
AU  - Perdiguero, Beatriz
AU  - García-Arriaza, Juan
AU  - Gonzalez-Fernandez, Nuria
AU  - Sorzano, Carlos O S
AU  - Jiménez, Laura
AU  - Jiménez, José Luis
AU  - Muñoz-Fernández, María Ángeles
AU  - Gatell, José M
AU  - Alcamí, José
AU  - Esteban, Mariano
AU  - López Bernaldo de Quirós, Juan Carlos
AU  - García, Felipe
AU  - Plana, Montserrat
PY  - 2017
DO  - 10.1371/journal.pone.0186602
SN  - 1932-6203
UR  - http://hdl.handle.net/20.500.12105/6880
AB  - BACKGROUND: We have previously shown that an HIV vaccine regimen including three doses of HIV-modified vaccinia virus Ankara vector expressing HIV-1 antigens from clade B (MVA-B) was safe and elicited moderate and durable (1 year) T-cell and antibody...
LA  - eng
PB  - Public Library of Science (PLOS)
KW  - AIDS Vaccines
KW  - Antibodies, Neutralizing
KW  - CD4-Positive T-Lymphocytes
KW  - CD8-Positive T-Lymphocytes
KW  - Enzyme-Linked Immunosorbent Assay
KW  - Flow Cytometry
KW  - HIV Antibodies
KW  - HIV-1
KW  - Healthy Volunteers
KW  - Humans
KW  - Placebos
KW  - Immunization, Secondary
TI  - Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization
TY  - journal article
ER  -